A New Drug For A Relentless Brain Disease
(By Jon Hamilton and Thomas Lu for NPR on October 5, 2022) ALS is a disease that gradually destroys the
Read More
2023 Part B Premium Is Going Down. Here’s Some Perspective.
(By Diane Omdahl, Contributor, for Forbes on October 4, 2022) The Centers for Medicare and Medicaid Services (CMS) released on Sept.
Read MoreThese LSD-based drugs seem to help mice with anxiety and depression — without the trip
(By Jon Hamilton for NPR on October 5, 2022) Drugs like magic mushrooms and LSD can act as powerful and
Read MoreSevere Sleep Apnea Diagnosis Panics Reporter Until He Finds a Simple, No-Cost Solution
(By Jay Hancock for Kaiser Health News on October 3, 2022) I woke up in a strange bedroom with 24
Read MoreNursing Home Surprise: Advantage Plans May Shorten Stays to Less Time Than Medicare Covers
(By Susan Jaffe for Kaiser Health News on October 4, 2022) After 11 days in a St. Paul, Minnesota, skilled
Read MoreThe 10 drugs most likely to be the 1st negotiated by Medicare
(By Rylee Wilson for Becker’s Hospital Review on September 30, 2022) The first drugs negotiated by Medicare are likely to
Read MoreTo prevent unnecessary biopsies, scientists train an AI model to predict breast cancer risk from MRI scans
By Jayne Williamson-Lee for Stat News on October 3, 2022 A biopsy that turns out to have benign results can
Read MoreWhat you need know about VA benefits in the aftermath of Hurricanes Fiona and Ian
(Source – news.va.gov) Recent hurricanes have caused incredible destruction, leaving millions to grapple with the devastating impact and loss of
Read MoreMedicare Advantage premiums to decrease
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage premiums will decrease for 2023, CMS said Sept. 29, continuing a
Read MoreFDA approves ALS drug from Amylyx, giving patients a much-needed treatment option
(By Damian Garde for STAT) The Food and Drug Administration approved a new medicine for ALS from Amylyx Pharmaceuticals on
Read More